Trial Profile
A Randomized, Single Dose Study to Determine the Safety and Pharmacokinetics of FP01 Lozenges in Healthy Volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 12 May 2022
Price :
$35
*
At a glance
- Drugs Memantine (Primary)
- Indications Cough
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Avalo Therapeutics; Cerecor
- 10 Apr 2014 New trial record